Results 1 to 10 of about 110,250 (249)
Avelumab use in Merkel cell carcinoma treatment
Nowotwory, 2022 Avelumab is a programmed death-ligand 1 (PD-L1) blocking human IgG1 lambda monoclonal antibody. It was the first immunotherapy to be approved for the treatment of MCC.
Monika Dudzisz-Śledź +4 more
doaj +1 more source
Cancer Control, 2021 Background: There is currently no consensus on optimal management of patients with primary or recurrent non-resectable/residual retroperitoneal sarcomas (RPS). The objective of this study was to document the outcomes of patients with primary or recurrent
Aleksandra Sobiborowicz +3 more
doaj +1 more source
Journal of Orthopaedic Surgery and Research, 2019 Background Osteosarcoma is the most common primary malignant bone tumor in adults and is usually located in the long bones. Standard treatment consists of perioperative chemotherapy and radical surgical resection.
Tomasz Goryń +5 more
doaj +1 more source
Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
World Journal of Surgical Oncology, 2019 Background The eighth edition of the American Joint Committee on Cancer (AJCC) staging system has been effective since January 2018. It has introduced some major changes in the localized/locoregional melanoma classification.
Pawel Teterycz +3 more
doaj +1 more source
Treatment of metastatic uveal melanoma
Nowotwory, 2022 Uveal melanoma is a rare malignancy with a poor prognosis. The risk of metastatic disease (mainly to the liver) exceeds 50% and is often observed many years after the primary treatment.
Mateusz M. Polaczek +1 more
doaj +1 more source
BMC Musculoskeletal Disorders, 2021 Background Like with all cancers, multidisciplinary team (MDT) meetings are the norm in bone and soft tissue tumour (BST) management too. Problem in attendance of specialists due to geographical location is the one of the key barriers to effective ...
Raja Bhaskara Rajasekaran +4 more
doaj +1 more source
Advances in the management of gastrointestinal stromal tumors (GISTs)
Nowotwory, 2020 Gastrointestinal stromal tumors are rare neoplasms developing from cells of Cajal in the gastrointestinal tract. The mainstay of such tumors treatment is surgery, whenever possible. The therapeutic management of inoperable and metastatic disease is based
Monika Dudzisz-Śledź, Piotr Rutkowski
doaj +1 more source
Radiology and Oncology, 2021 Standard therapy for localised, resectable high risk soft tissue sarcomas consists of wide excision and radiotherapy over several weeks. This treatment schedule is hardly feasible in geriatric and frail patients.
Potkrajcic Vlatko +7 more
doaj +1 more source
Current advances in radiotherapy for soft tissue sarcomas
Nowotwory, 2020 Radiotherapy (RT) is a part of the routine treatment of locally advanced or high-grade soft-tissue sarcomas (STS). However, RT has changed significantly over the last 20 years. Modern RT techniques have extended its potential application in STS treatment.
Mateusz J. Spałek, Aneta M. Borkowska
doaj +1 more source